Palivizumab

Palivizumab is a Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody. The mechanism of action of palivizumab is as a Fusion Protein Inhibitor. It is grouped under the following drug class(es): Monoclonal antibodies. The directory classifies it as a commercial API with a biotechnology source/manufacturing origin. Other names for this substance include Immunoglobulin G1 and palivizumabum. Its PubChem CID is 481101776.

CAS No 188039-54-5
Molecular Formula C6470H10056N1700O2008S50
Molecular Weight 148,000 Daltons

Frequently Asked Questions